These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High-grade cervical abnormalities and screening intervals in New South Wales, Australia. Schindeler S, Morrell S, Zuo Y, Baker D. J Med Screen; 2008 May; 15(1):36-43. PubMed ID: 18416954 [Abstract] [Full Text] [Related]
5. Cervical cancer screening in a rural population of Zimbabwe. Thistle PJ, Chirenje ZM. Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642 [Abstract] [Full Text] [Related]
7. [Cervical cancer screening and associated treatment costs in France]. Bergeron C, Breugelmans JG, Bouée S, Lorans C, Bénard S, Rémy V. Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085 [Abstract] [Full Text] [Related]
8. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, Anttila A, Nieminen P, Prendiville W. Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546 [Abstract] [Full Text] [Related]
9. A retrospective study of cervical screening in women under 25 years (2005-2009). Ali AA, Richardson D, Hill N. Arch Gynecol Obstet; 2013 Apr; 287(4):765-9. PubMed ID: 23183714 [Abstract] [Full Text] [Related]
10. Pap test--with or without vaginal smear? Milicić-Juhas V, Perić M, Pajtler M, Prvulović I, Curzik D. Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636 [Abstract] [Full Text] [Related]
13. The agreement between self-reported cervical smear abnormalities and screening programme records. Canfell K, Beral V, Green J, Cameron R, Baker K, Brown A. J Med Screen; 2006 Mar; 13(2):72-5. PubMed ID: 16792828 [Abstract] [Full Text] [Related]
14. Low-cost technology for screening uterine cervical cancer. Parashari A, Singh V, Sehgal A, Satyanarayana L, Sodhani P, Gupta MM. Bull World Health Organ; 2000 Mar; 78(8):964-7. PubMed ID: 10994279 [Abstract] [Full Text] [Related]
16. Value of normal colposcopy after an abnormal cervical smear report. Luesley D, Downey G. J Low Genit Tract Dis; 2009 Jan; 13(1):33-7. PubMed ID: 19098604 [Abstract] [Full Text] [Related]
17. A longitudinal study of sexual functioning in women referred for colposcopy: a 2-year follow up. Hellsten C, Lindqvist PG, Sjöström K. BJOG; 2008 Jan; 115(2):205-11. PubMed ID: 17903228 [Abstract] [Full Text] [Related]
18. Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer. Tergas AI, Havrilesky LJ, Fader AN, Guntupalli SR, Huh WK, Massad LS, Rimel BJ. Gynecol Oncol; 2013 Sep; 130(3):421-5. PubMed ID: 23747836 [Abstract] [Full Text] [Related]
19. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid. Dhaubhadel P, Vaidya A, Choudhary P. JNMA J Nepal Med Assoc; 2008 Sep; 47(170):71-6. PubMed ID: 18709035 [Abstract] [Full Text] [Related]
20. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Kitchener HC, Blanks R, Cubie H, Desai M, Dunn G, Legood R, Gray A, Sadique Z, Moss S, MAVARIC Trial Study Group. Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]